Young Richard Simon, Deslandes Paul, Cooper Jennifer, Williams Huw, Kenkre Joyce, Carson-Stevens Andrew
University of South Wales, Pontypridd, Rhondda Cynon Taff, UK.
Cardiff University, Cardiff, UK.
Ther Adv Drug Saf. 2020 Jun 7;11:2042098620922748. doi: 10.1177/2042098620922748. eCollection 2020.
Lithium is a drug with a narrow therapeutic range and has been associated with a number of serious adverse effects. This study aimed to characterise primary care lithium-related patient safety incidents submitted to the National Reporting and Learning System (NRLS) database with respect to incident origin, type, contributory factors and outcome. The intention was to identify ways to minimise risk to future patients by examining incidents with a range of harm outcomes.
A mixed methods analysis of patient safety incident reports related to lithium was conducted. Data from healthcare organisations in England and Wales were extracted from the NRLS database. An exploratory descriptive analysis was undertaken to characterise the most frequent incident types, the associated chain of events and other contributory factors.
A total of 174 reports containing the term 'lithium' were identified. Of these, 41 were excluded and, from the remaining 133 reports, 138 incidents were identified and coded. Community pharmacies reported 100 incidents (96 dispensing related, two administration, two other), general practitioner (GP) practices filed 22 reports and 16 reports originated from other sources. A total of 99 dispensing-related incidents were recorded, 39 resulted from the wrong medication dispensed, 31 the wrong strength, 8 the wrong quantity and 21 other. A total of 128 contributory factors were identified overall; for dispensing incidents, the most common related to medication storage/packaging ( = 41), and 'mistakes' ( = 22), whereas no information regarding contributory factors was provided in 41 reports.
Despite the established link between medication packaging and the risk of dispensing errors, our study highlighted storage and packaging as the most commonly described contributory factors to dispensing errors. The absence of certain relevant data limited the ability to fully characterise a number of reports. This highlighted the need to include clear and complete information when submitting reports. This, in turn, may help to better inform the further development of interventions designed to reduce the risk of incidents and improve patient safety.
锂是一种治疗窗狭窄的药物,与多种严重不良反应相关。本研究旨在根据事件起源、类型、促成因素和结果,对提交至国家报告和学习系统(NRLS)数据库的基层医疗中与锂相关的患者安全事件进行特征描述。目的是通过检查一系列伤害结果的事件,确定将未来患者风险降至最低的方法。
对与锂相关的患者安全事件报告进行混合方法分析。从NRLS数据库中提取英格兰和威尔士医疗机构的数据。进行探索性描述性分析,以确定最常见的事件类型、相关事件链和其他促成因素。
共识别出174份包含“锂”一词的报告。其中,41份被排除,从其余133份报告中,识别并编码了138起事件。社区药房报告了100起事件(96起与配药有关,2起与给药有关,2起其他),全科医生(GP)诊所提交了22份报告,16份报告来自其他来源。共记录了99起与配药有关的事件,39起是由于配错药物,31起是由于浓度错误,8起是由于剂量错误,21起是其他原因。总体共识别出128个促成因素;对于配药事件,最常见的与药物储存/包装(=41)和“失误”(=22)有关,而41份报告未提供促成因素的相关信息。
尽管药物包装与配药错误风险之间已确立联系,但我们的研究强调储存和包装是配药错误最常描述的促成因素。某些相关数据的缺失限制了全面描述许多报告的能力。这凸显了提交报告时纳入清晰完整信息的必要性。反过来,这可能有助于为旨在降低事件风险和提高患者安全的干预措施的进一步发展提供更好的信息。